Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06268847Not ApplicableCompleted

Efficacy of Marine By-product Hydrolysate on the Reduction of Atopic Dermatitis Symptoms

Role: lead

NCT04910399Not ApplicableCompleted

Development of an Innovative Health Ingredient From Marine By-products for the Healthy Aging

Role: lead

NCT04983355Not ApplicableCompleted

Efficacy of the Marine Based Nutritional Supplement Peptidyss® on Sleep and Anxiety

Role: lead

NCT04420091Not ApplicableCompleted

Hydrolyzed Fish Cartilage Effect on Knee Joint Functionality and Discomfort in Adult Population

Role: lead

All 4 trials loaded